349
Views
21
CrossRef citations to date
0
Altmetric
Original

Transcription factor GATA-1 and Down syndrome leukemogenesis

, , &
Pages 986-997 | Accepted 04 Nov 2005, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Julie Ross, Lionel Mavoungou, Emery H. Bresnick & Eric Milot. (2012) GATA-1 Utilizes Ikaros and Polycomb Repressive Complex 2 To Suppress Hes1 and To Promote Erythropoiesis. Molecular and Cellular Biology 32:18, pages 3624-3638.
Read now
Andrew J. Woo, Tyler B. Moran, Yocheved L. Schindler, Seong-Kyu Choe, Nathaniel B. Langer, Matthew R. Sullivan, Yuko Fujiwara, Barry H. Paw & Alan B. Cantor. (2008) Identification of ZBP-89 as a Novel GATA-1-Associated Transcription Factor Involved in Megakaryocytic and Erythroid Development. Molecular and Cellular Biology 28:8, pages 2675-2689.
Read now

Articles from other publishers (19)

Avanti Gupte, Eman T. Al-Antary, Holly Edwards, Yaddanapudi Ravindranath, Yubin Ge & Jeffrey W. Taub. (2022) The paradox of Myeloid Leukemia associated with Down syndrome. Biochemical Pharmacology 201, pages 115046.
Crossref
Sina Al-Kershi, Richard Golnik, Marius Flasinski, Katharina Waack, Mareike Rasche, Ursula Creutzig, Michael Dworzak, Dirk Reinhardt & Jan-Henning Klusmann. (2021) Recommendations for Diagnosis and Treatment of Children with Transient Abnormal Myelopoiesis (TAM) and Myeloid Leukemia in Down Syndrome (ML-DS). Klinische Pädiatrie 233:06, pages 267-277.
Crossref
Laura Jardine, Simone Webb, Issac Goh, Mariana Quiroga Londoño, Gary Reynolds, Michael Mather, Bayanne Olabi, Emily Stephenson, Rachel A. Botting, Dave Horsfall, Justin Engelbert, Daniel Maunder, Nicole Mende, Caitlin Murnane, Emma Dann, Jim McGrath, Hamish King, Iwo Kucinski, Rachel Queen, Christopher D. Carey, Caroline Shrubsole, Elizabeth Poyner, Meghan Acres, Claire Jones, Thomas Ness, Rowen Coulthard, Natalina Elliott, Sorcha O’Byrne, Myriam L. R. Haltalli, John E. Lawrence, Steven Lisgo, Petra Balogh, Kerstin B. Meyer, Elena Prigmore, Kirsty Ambridge, Mika Sarkin Jain, Mirjana Efremova, Keir Pickard, Thomas Creasey, Jaume Bacardit, Deborah Henderson, Jonathan Coxhead, Andrew Filby, Rafiqul Hussain, David Dixon, David McDonald, Dorin-Mirel Popescu, Monika S. Kowalczyk, Bo Li, Orr Ashenberg, Marcin Tabaka, Danielle Dionne, Timothy L. Tickle, Michal Slyper, Orit Rozenblatt-Rosen, Aviv Regev, Sam Behjati, Elisa Laurenti, Nicola K. Wilson, Anindita Roy, Berthold Göttgens, Irene Roberts, Sarah A. Teichmann & Muzlifah Haniffa. (2021) Blood and immune development in human fetal bone marrow and Down syndrome. Nature 598:7880, pages 327-331.
Crossref
Neha Bhatnagar, Laure Nizery, Oliver Tunstall, Paresh Vyas & Irene Roberts. (2016) Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update. Current Hematologic Malignancy Reports 11:5, pages 333-341.
Crossref
Christina Halsey, Marie Docherty, Mhairi McNeill, Derek Gilchrist, Michelle Le Brocq, Brenda Gibson & Gerard Graham. (2012) The GATA1s isoform is normally down-regulated during terminal haematopoietic differentiation and over-expression leads to failure to repress MYB, CCND2 and SKI during erythroid differentiation of K562 cells. Journal of Hematology & Oncology 5:1.
Crossref
Dean Nižetić & Jürgen Groet. (2012) Tumorigenesis in Down's syndrome: big lessons from a small chromosome. Nature Reviews Cancer 12:10, pages 721-732.
Crossref
W. Ayed, L. Gouas, F. Penault-Llorca, A. Amouri, A. Tchirkov & P. Vago. (2012) Trisomie 21 et cancers. Morphologie 96:314-315, pages 57-66.
Crossref
Patrick K. Campbell, Yang Zong, Shengping Yang, Sheng Zhou, Jeffrey E. Rubnitz & Brian P. Sorrentino. (2011) Identification of a novel, tissue-specific ABCG2 promoter expressed in pediatric acute megakaryoblastic leukemia. Leukemia Research 35:10, pages 1321-1329.
Crossref
Lucia R. Wolgast, Linda A. Cannizzarro, K. H. Ramesh, Xiaonan Xue, Dan Wang, Pritish K. Bhattacharyya, Jerald Z. Gong, Christine McMahon, Joseph M. Albanese, Jaya L. Sunkara & Howard Ratech. (2011) Spectrin Isoforms. American Journal of Clinical Pathology 136:2, pages 300-308.
Crossref
P. GARCÍA, O. BERLANGA, A. VEGIOPOULOS, P. VYAS & J. FRAMPTON. (2011) c‐Myb and GATA‐1 alternate dominant roles during megakaryocyte differentiation. Journal of Thrombosis and Haemostasis 9:8, pages 1572-1581.
Crossref
J.L. Fuster Soler, A. Norton, A. Galera Miñarro, M. Bermúdez Cortés, M.E. Llinares Riestra & F. Ortuño Giner. (2011) Análisis de GATA1 en los trastornos mieloproliferativos asociados a la trisomía 21. Anales de Pediatría 74:1, pages 31-37.
Crossref
Christa Fonatsch. (2010) The role of chromosome 21 in hematology and oncology. Genes, Chromosomes and Cancer 49:6, pages 497-508.
Crossref
Jeffrey W. Taub, Yubin Ge & Yaddanapudi Ravindranath. 2010. Molecularly Targeted Therapy for Childhood Cancer. Molecularly Targeted Therapy for Childhood Cancer 109 122 .
Ming Yu, Laura Riva, Huafeng Xie, Yocheved Schindler, Tyler B. Moran, Yong Cheng, Duonan Yu, Ross Hardison, Mitchell J. Weiss, Stuart H. Orkin, Bradley E. Bernstein, Ernest Fraenkel & Alan B. Cantor. (2009) Insights into GATA-1-Mediated Gene Activation versus Repression via Genome-wide Chromatin Occupancy Analysis. Molecular Cell 36:4, pages 682-695.
Crossref
Serena De Vita, Anny Devoy, Juergen Groet, Božo Krušlin, Ivana Kuzmić-Prusac & Dean Nižetić. (2008) Megakaryocyte hyperproliferation without GATA1 mutation in foetal liver of a case of Down syndrome with hydrops foetalis . British Journal of Haematology 143:2, pages 300-303.
Crossref
Linda Wolff, Steven J. Ackerman & Giuseppina Nucifora. (2008) Meeting report: Seventh International Workshop on Molecular Aspects of Myeloid Stem Cell Development and Leukemia, Annapolis, MD, May 13–16, 2007. Experimental Hematology 36:5, pages 523-532.
Crossref
A Wickrema & J D Crispino. (2007) Erythroid and megakaryocytic transformation. Oncogene 26:47, pages 6803-6815.
Crossref
Serena De Vita, Claire Mulligan, Suzanne McElwaine, Franca Dagna‐Bricarelli, Monica Spinelli, Giuseppe Basso, Dean Nizetic & Jürgen Groet. (2007) Loss‐of‐function JAK3 mutations in TMD and AMKL of Down syndrome . British Journal of Haematology 137:4, pages 337-341.
Crossref
David Patterson. (2007) Genetic mechanisms involved in the phenotype of Down syndrome. Mental Retardation and Developmental Disabilities Research Reviews 13:3, pages 199-206.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.